Biogen Ma Inc. v. Emd Serono, Inc., Pfizer Inc.

United States Court of Appeals
for the Federal Circuit
______________________

November 20, 2020

ERRATA
______________________

Appeal No. 2019-1133

BIOGEN MA INC.,
Plaintiff -Appellee

v.

EMD SERONO, INC., PFIZER INC.,
Defendants-Appellants

BAYER HEALTHCARE PHARMACEUTICALS INC.,
NOVARTIS PHARMACEUTICALS CORPORATION,
Defendants

Decided: September 28, 2020
Precedential Opinion
______________________

Please make the following changes:

On page 8, lines 17–20, change “emphasized that
whereas the attached carbohydrate groups in na-
tive IFN-β protein were glycosolated, the attached
carbohydrate groups in recombinant IFN-β were
not glycosolated,” to —explained that the glycosyl-
ation patterns in native IFN-β and recombinant
IFN-β were different,—.
Case: 19-1133 Document: 98 Page: 1 Filed: 11/20/2020